Please login to the form below

Not currently logged in
Email:
Password:

Cancer Research

This page shows the latest Cancer Research news and features for those working in and with pharma, biotech and healthcare.

Call for genetic tests to bring personalised medicine to children with cancer

Call for genetic tests to bring personalised medicine to children with cancer

Experts at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust want the NHS to dramatically scale up access to genetic sequencing for children, so that doctors ... The plea for more funding and a change in clinical

Latest news

  • CRUK forges £30m ‘post-Brexit’ R&D alliance CRUK forges £30m ‘post-Brexit’ R&D alliance

    Cancer Research UK has joined forces with two peer organisations in Italy and Spain to fund half a dozen R&D projects – and to show that Brexit need not be a ... No single organisation or country is going to beat cancer on its own, ”commented Dr Iain

  • London cancer hub launched by Cancer Research UK London cancer hub launched by Cancer Research UK

    London cancer hub launched by Cancer Research UK. Specialist centres unite to collaborate on immunotherapies such as CAR-T. ... An ambitious plan to turn London into a ‘powerhouse’of cancer research has been launched, backed with £14m ($18m) in

  • Boehringer bolts on another immuno-oncology company Boehringer bolts on another immuno-oncology company

    We are committed to investing in early research with promise and where our expertise best complements the strengths of our partners.”. ... collaborations. “Using a dual approach for potential treatment options, specifically combining immuno-oncology

  • UK start-up Azeria emerges with £4m drug discovery pot for cancer UK start-up Azeria emerges with £4m drug discovery pot for cancer

    A new UK biotech, Azeria Therapeutics, has been set up to build on scientific discoveries coming out of Cancer Research UK’s lab at the University of Cambridge. ... Boston and has been at the CRUK University of Cambridge lab since 2006, currently as a

  • It’s a no for Yescarta, says NICE on heels of EU approval It’s a no for Yescarta, says NICE on heels of EU approval

    T Yescarta, rejecting use of the cancer immunotherapy by the NHS in draft guidance. ... Commenting on the decision, Professor Raj Chopra, head of cancer therapeutics at The Institute of Cancer Research in London, said:.

More from news
Approximately 21 fully matching, plus 352 partially matching documents found.

Latest Intelligence

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    Open-minded culture. Like the new HQ’s construction, there have been setbacks – such as the failure of two immunotherapies in the MYSTIC lung cancer trial last year – but the company ... The park is also home to the Cancer Research UK Institute, a

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    up innate immune responses, and Cancer Research UK is repurposing an AZ chemokine CCR4 receptor drug (AZD2098) originally developed for asthma in kidney cancer. ... Additional work is going to stratify tumours according to these molecular signatures, and

  • 30 Women Leaders in UK Healthcare (part 2)

    Based at Pfizer’s UK research centre in Sandwich, Kent, Melissa is  part of Pfizer’s Technology &Innovation team. ... Skipper has a PhD in genetics from the University of Cambridge, UK, and worked for a short time as postdoctoral researcher at the

  • 30 women leaders in UK healthcare (part 3) 30 women leaders in UK healthcare (part 3)

    As Director of the MRC Clinical Trials Unit she has led the National Cancer Research Network in applying clinical trials for the improvement of cancer management in the UK. ... She now sits in the House of Lords as an independent peer, and is chair of

  • Cancer in The Information Age: are we illuminated or inundated? Cancer in The Information Age: are we illuminated or inundated?

    The American Association for Cancer Research defines it not as a singular concept, but a collection of more than 200 diseases. ... We are now on the crest of a new wave in cancer care.

More from intelligence
Approximately 0 fully matching, plus 26 partially matching documents found.

Latest appointments

  • Celgene boosts CAR-T stake again with Bluebird Bio deal Celgene boosts CAR-T stake again with Bluebird Bio deal

    At the time, lead investigator James Kochenderfer from the Center for Cancer Research at the National Cancer Institute in Bethesda said: “We have patients who have a sustained response and have ... and a $1.1bn agreement to acquire Impact Biomedicines

  • José Baselga joins BMS’ board of directors José Baselga joins BMS’ board of directors

    Dr Baselga is currently the physician in chief at Memorial Sloan Kettering Cancer Center, where he is responsible for the management of patients care, enhancing and expanding programmes in clinical and ... Association for Cancer Research.

  • Glythera strengthens its scientific advisory board and appoints CSO Glythera strengthens its scientific advisory board and appoints CSO

    Dr Lutz was previously vice president of translation research and development at ImmunoGen, where he was responsible for all early-stage ADC development programmes. ... Additionally, Dr Jon Roffey joins Glythera ’s scientific advisory board (SAB) from

  • Lilly bolsters its oncology team Lilly bolsters its oncology team

    s cancer programme, associate director for strategic relations for the Duke Cancer Institute among other roles. ... cancer research, especially metastatic breast cancer, where she has led programmes that resulted in numerous ground-breaking regulatory

  • Storm Therapeutics strengthens its board Storm Therapeutics strengthens its board

    Workman currently serves The Institute of Cancer Researc h as its president and chief executive officer and has formerly served as head of the division of cancer therapeutics at Cancer Research ... world class cancer institute and being a founder of

More from appointments
Approximately 1 fully matching, plus 30 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics